Literature DB >> 34932890

Body composition and cardiometabolic health across the menopause transition.

Kara L Marlatt1, Dori R Pitynski-Miller2,3, Kathleen M Gavin2,3, Kerrie L Moreau2,3, Edward L Melanson2,3,4, Nanette Santoro5, Wendy M Kohrt2,3.   

Abstract

Every year, 2 million women reach menopause in the United States, and they may spend 40% or more of their life in a postmenopausal state. In the years immediately preceding menopause-known as the menopause transition (or perimenopause)-changes in hormones and body composition increase a woman's overall cardiometabolic risk. In this narrative review, we summarize the changes in weight, body composition, and body fat distribution, as well as the changes in energy intake, energy expenditure, and other cardiometabolic risk factors (lipid profile, glucose metabolism, sleep health, and vascular function), that occur during the menopause transition. We also discuss the benefits of lifestyle interventions in women in the earlier stages of menopause before these detrimental changes occur. Finally, we discuss how to include perimenopausal women in research studies so that women across the life-span are adequately represented.
© 2021 The Obesity Society.

Entities:  

Mesh:

Year:  2022        PMID: 34932890      PMCID: PMC8972960          DOI: 10.1002/oby.23289

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  155 in total

1.  Induction of calcium-dependent nitric oxide synthases by sex hormones.

Authors:  C P Weiner; I Lizasoain; S A Baylis; R G Knowles; I G Charles; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

Review 2.  HDL and the menopause.

Authors:  Samar R El Khoudary
Journal:  Curr Opin Lipidol       Date:  2017-08       Impact factor: 4.776

3.  Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women's Angiographic Vitamin and Estrogen (WAVE) trial.

Authors:  Mark Kelemen; Dhananjay Vaidya; David D Waters; Barbara V Howard; Frederick Cobb; Naji Younes; Mark Tripputti; Pamela Ouyang
Journal:  Atherosclerosis       Date:  2004-12-28       Impact factor: 5.162

4.  Blocking FSH induces thermogenic adipose tissue and reduces body fat.

Authors:  Peng Liu; Yaoting Ji; Tony Yuen; Elizabeth Rendina-Ruedy; Victoria E DeMambro; Samarth Dhawan; Wahid Abu-Amer; Sudeh Izadmehr; Bin Zhou; Andrew C Shin; Rauf Latif; Priyanthan Thangeswaran; Animesh Gupta; Jianhua Li; Valeria Shnayder; Samuel T Robinson; Yue Eric Yu; Xingjian Zhang; Feiran Yang; Ping Lu; Yu Zhou; Ling-Ling Zhu; Douglas J Oberlin; Terry F Davies; Michaela R Reagan; Aaron Brown; T Rajendra Kumar; Solomon Epstein; Jameel Iqbal; Narayan G Avadhani; Maria I New; Henrik Molina; Jan B van Klinken; Edward X Guo; Christoph Buettner; Shozeb Haider; Zhuan Bian; Li Sun; Clifford J Rosen; Mone Zaidi
Journal:  Nature       Date:  2017-05-24       Impact factor: 49.962

5.  Reduced rate of energy expenditure as a risk factor for body-weight gain.

Authors:  E Ravussin; S Lillioja; W C Knowler; L Christin; D Freymond; W G Abbott; V Boyce; B V Howard; C Bogardus
Journal:  N Engl J Med       Date:  1988-02-25       Impact factor: 91.245

6.  Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function.

Authors:  K C Chiu; P Cohan; N P Lee; L M Chuang
Journal:  Diabetes Care       Date:  2000-09       Impact factor: 19.112

7.  Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN).

Authors:  Gail A Greendale; MaryFran Sowers; Weijuan Han; Mei-Hua Huang; Joel S Finkelstein; Carolyn J Crandall; Jennifer S Lee; Arun S Karlamangla
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

8.  Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.

Authors:  Alka M Kanaya; David Herrington; Eric Vittinghoff; Feng Lin; Deborah Grady; Vera Bittner; Jane A Cauley; Elizabeth Barrett-Connor
Journal:  Ann Intern Med       Date:  2003-01-07       Impact factor: 25.391

9.  Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.

Authors:  Cynthia A Stuenkel; Susan R Davis; Anne Gompel; Mary Ann Lumsden; M Hassan Murad; JoAnn V Pinkerton; Richard J Santen
Journal:  J Clin Endocrinol Metab       Date:  2015-10-07       Impact factor: 5.958

10.  Assessing the validity of body mass index standards in early postmenopausal women.

Authors:  Robert M Blew; Luis B Sardinha; Laura A Milliken; Pedro J Teixeira; Scott B Going; Dawna L Ferreira; Margaret M Harris; Linda B Houtkooper; Timothy G Lohman
Journal:  Obes Res       Date:  2002-08
View more
  6 in total

1.  The Mediation Effect of Body Composition on the Association Between Menopause and Hyperuricemia: Evidence From China National Health Survey.

Authors:  Huijing He; Li Pan; Feng Liu; Xiaolan Ren; Ze Cui; Lize Pa; Jingbo Zhao; Dingming Wang; Jianwei Du; Hailing Wang; Xianghua Wang; Xia Peng; Chengdong Yu; Ye Wang; Guangliang Shan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

2.  "It just seems like people are talking about menopause, but nobody has a solution": A qualitative exploration of menopause experiences and preferences for weight management among Black women.

Authors:  Chelsea L Kracht; Jessica St Romain; Julie C Hardee; Nanette Santoro; Leanne M Redman; Kara L Marlatt
Journal:  Maturitas       Date:  2021-11-07       Impact factor: 5.110

3.  NAMS 2021 Utian Translational Science SymposiumSeptember 2021, Washington, DCCharting the path to health in midlife and beyond: the biology and practice of wellness.

Authors:  Nanette F Santoro; Helen L Coons; Samar R El Khoudary; C Neill Epperson; Julianne Holt-Lunstad; Hadine Joffe; Sarah H Lindsey; Kara L Marlatt; Patti Montella; Gloria Richard-Davis; Bonny Rockette-Wagner; Marcel E Salive; Cynthia Stuenkel; Rebecca C Thurston; Nancy Woods; Holly Wyatt
Journal:  Menopause       Date:  2022-05-01       Impact factor: 3.310

4.  Hepatic adropin is regulated by estrogen and contributes to adverse metabolic phenotypes in ovariectomized mice.

Authors:  Joshua Stokar; Irina Gurt; Einav Cohen-Kfir; Oran Yakubovsky; Noa Hallak; Hadar Benyamini; Natan Lishinsky; Neta Offir; Joseph Tam; Rivka Dresner-Pollak
Journal:  Mol Metab       Date:  2022-03-29       Impact factor: 8.568

5.  Correlations between Fatty Acid Profile and Body Fat Distribution in Postmenopausal Women-A Cross Sectional Study.

Authors:  Anna Maria Cybulska; Kamila Rachubińska; Karolina Skonieczna-Żydecka; Arleta Drozd; Jolanta Pawlik; Ewa Stachowska; Aneta Cymbaluk-Płoska; Elżbieta Grochans
Journal:  Nutrients       Date:  2022-09-18       Impact factor: 6.706

Review 6.  Roles of estrogens, estrogen-like compounds, and endocrine disruptors in adipocytes.

Authors:  Fernando Lizcano
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-21       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.